Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2052 | 2306 | 23.2 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
126 | 23061 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//MYCOPHENOLIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYCLOSPORINE G | Author keyword | 11 | 69% | 0% | 9 |
2 | CYCLOSPORINE METABOLITES | Author keyword | 9 | 83% | 0% | 5 |
3 | CYCLOSPORIN G | Author keyword | 8 | 100% | 0% | 5 |
4 | ERYTHROCYTE TO PLASMA DISTRIBUTION | Author keyword | 6 | 100% | 0% | 4 |
5 | ISOCYCLOSPORIN A | Author keyword | 6 | 100% | 0% | 4 |
6 | ENZYME MULTIPLIED IMMUNOASSAY | Author keyword | 5 | 63% | 0% | 5 |
7 | FLUORESCENCE POLARIZATION IMMUNOASSAY | Author keyword | 4 | 14% | 1% | 23 |
8 | CYCLOSPORINE A PHARMACOKINETICS | Author keyword | 3 | 100% | 0% | 3 |
9 | AM4N | Author keyword | 2 | 67% | 0% | 2 |
10 | CYCLOSPORINS | Author keyword | 2 | 17% | 0% | 10 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NVA2 CYCLOSPORINE | 57 | 95% | 1% | 19 |
2 | ENZYME MULTIPLIED IMMUNOASSAY | 10 | 46% | 1% | 17 |
3 | MONITORING CYCLOSPORINE | 10 | 58% | 0% | 11 |
4 | 9 METABOLITES | 8 | 100% | 0% | 5 |
5 | TOLYPOCLADIUM TERRICOLA | 6 | 80% | 0% | 4 |
6 | FLUORESCENCE POLARIZATION IMMUNOASSAY | 6 | 13% | 2% | 43 |
7 | CONVENTIONAL IMMUNOSUPPRESSION | 5 | 45% | 0% | 9 |
8 | A OXIDASE | 5 | 43% | 0% | 9 |
9 | A METABOLITES | 5 | 63% | 0% | 5 |
10 | AXSYM | 3 | 50% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CYCLOSPORINE CLINICAL PHARMACOKINETICS | 1993 | 240 | 148 | 80% |
DRUG-THERAPY - CYCLOSPORINE | 1989 | 1562 | 91 | 25% |
CLINICAL PHARMACOKINETICS OF CYCLOSPORINE | 1986 | 429 | 62 | 89% |
CRITICAL ISSUES IN CYCLOSPORINE MONITORING - REPORT OF THE TASK-FORCE ON CYCLOSPORINE MONITORING | 1987 | 229 | 110 | 85% |
FACTORS INFLUENCING THE PHARMACOKINETICS OF CYCLOSPORINE IN MAN | 1991 | 125 | 113 | 87% |
METHODOLOGICAL AND CLINICAL ASPECTS OF CYCLOSPORINE MONITORING - REPORT OF THE ASSOCIATION OF CLINICAL BIOCHEMISTS TASK-FORCE | 1994 | 49 | 123 | 77% |
Clinically significant drug interactions with cyclosporin - An update | 1996 | 135 | 256 | 38% |
ELECTIVE CYCLOSPORINE WITHDRAWAL AFTER RENAL-TRANSPLANTATION - A METAANALYSIS | 1993 | 82 | 72 | 83% |
Distribution of cyclosporin in organ transplant recipients | 2002 | 62 | 102 | 62% |
CYCLOSPORINE METABOLISM IN TRANSPLANT PATIENTS | 1993 | 108 | 275 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOCHEM CENT | 1 | 50% | 0.0% | 1 |
2 | GRP PROCESADO DIGITAL SENALES | 1 | 50% | 0.0% | 1 |
3 | IST SEMIOT CHIRURG | 1 | 50% | 0.0% | 1 |
4 | MEDCLIN PHARMACOL SERV | 1 | 50% | 0.0% | 1 |
5 | SERV ANAT PATOL MED INTERNA | 1 | 50% | 0.0% | 1 |
6 | SERV FAMACOL CLIN | 1 | 50% | 0.0% | 1 |
7 | UNIV HOSP MED SOCIAL | 1 | 50% | 0.0% | 1 |
8 | UROL TRANSPLANTAT UNIT | 1 | 50% | 0.0% | 1 |
9 | BIOMED BIOTECHNOL BBZ | 0 | 33% | 0.0% | 1 |
10 | HOSP PHARM TSUKINOWA CHO | 0 | 33% | 0.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000277568 | NEORAL//C2 MONITORING//C 2 MONITORING |
2 | 0.0000200221 | CYCLOSPORINE A//CYCLOSPORINE NEPHROTOXICITY//NEPHROL HEM HE E TRANSPLANTAT |
3 | 0.0000172177 | AUTORADIOGRAPHIC TRACKING//BOVINE SERUM ALBUMIN NEPHRITIS//CIENCIAS CLIN 1 |
4 | 0.0000168050 | STEROID WITHDRAWAL//CORTICOSTEROID WITHDRAWAL//EARLY STEROID WITHDRAWAL |
5 | 0.0000126253 | ACRODERMATITIS CONTINUA OF HALLOPEAU//VOCLOSPORIN//MICROEMULSION FORMULATION |
6 | 0.0000081888 | UROLOGICAL EMERGENCIES//GASTROINTESTINAL COMPLICATIONS KIDNEY TRANSPLANTATION//BILIARY LIPID |
7 | 0.0000077010 | RENAL ALLOGRAFT RUPTURE//ALLOGRAFT RUPTURE//ACUTE KIDNEY TUBULAR NECROSIS |
8 | 0.0000065306 | POSTTRANSPLANT HYPERLIPIDEMIA//ABT LEBENSMITTELSICHERHEIT 1//APOLIPOPROTEIN DISTRIBUTION |
9 | 0.0000062060 | CYP3A5//TACROLIMUS//CYTOCHROME P450 3A5 |
10 | 0.0000060122 | OKT3//MUROMONAB CD3//ANTI OKT3 ANTIBODIES |